# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-22T14:03:35.409668

---

**Idea Fidelity**  
The paper closely follows the original idea manifest: it leverages CDC COMEC medicolegal death-investigation (MDI) classifications, NCHS model-based county overdose estimates, and contiguous within-state county pairs to estimate a causal detection gap between elected coroners and appointed medical examiners. Key elements—border-county variation, state fixed effects, national undercount calculation, and discussion of measurement error consequences—are all present. One divergence is that the manifest emphasized unspecified-vs–drug-specific classification shares, while the paper ends up estimating total drug overdose death rates (due to the limitation noted in the discussion); the broader manifestation of the measurement problem remains but the specific outcome is adjusted accordingly.

---

**Summary**  
This empirical note estimates how the institutional type of county medicolegal death investigations (coroner vs. medical examiner) affects measured drug overdose mortality. Using within-state border-county comparisons over 2003–2021, it documents a statistically significant “detection gap” of roughly 2.6 fewer recorded overdoses per 100,000 in coroner counties, which widens after 2015 and implies an annual national undercount of ~2,356 deaths. The paper argues that this systematic measurement error distorts both policy resource allocation and observational research that relies on county-level overdose data.

---

**Essential Points**

1. **Identification hinges on conditional comparability of adjacent counties.** The border-pair strategy is appropriate, but the paper does not demonstrate that the observable or unobservable determinants of true overdose risk are balanced within these pairs. Pre-treatment balancing tests (e.g., demographic trends, prior overdose trajectories) or placebo outcomes (non-forensic causes) within the border sample are essential to bolster the assumption that coroner assignment is “as good as random” conditional on adjacency.

2. **The extrapolation to a national undercount depends critically on the internal validity of the border comparison.** Without directly showing that the local detection gap generalizes beyond border counties (especially in states that are entirely coroner or entirely medical examiner), the national adjustment risks overreach. The authors should clarify whether border counties are representative of broader coroner counties or, alternatively, provide bounds that acknowledge this limitation.

3. **Outcome measurement and interpretation require more nuance.** Because the available outcome is the total drug overdose rate (not the unspecified share), the paper interprets the estimated gap as “measurement error.” Yet lower recorded rates in coroner counties could also reflect true differences in mortality (e.g., lower supply) that persist after conditioning. The discussion in Section 4 partially addresses this, but the empirical section should include placebo tests (e.g., heart disease/cancer deaths) or richer controls (e.g., prescribing rates, law enforcement variables if available) to credibly rule out differential trends in true mortality.

If these issues cannot be satisfactorily resolved, I would recommend rejection; they directly affect the causal claim and the paper’s broader policy implications.

---

**Suggestions**

1. **Strengthen balance and placebo evidence.** Within the border-pair sample, show that pre-2003 trends in overdose mortality and/or non-drug mortality (e.g., heart disease) do not differ systematically by MDI type. A simple difference-in-differences event-study or graphic can illustrate whether coroner and ME counties were trending similarly before the opioid surge. Additionally, include placebo regressions where the dependent variable is a cause of death unlikely to depend on forensic quality (e.g., cancer). If the coefficient is zero, it supports the measurement-error interpretation.

2. **Characterize the border-pair sample more fully.** Provide summary statistics (and perhaps maps) showing how border counties compare to the broader set of coroner counties in terms of demographics, urbanicity, and overdose-levels. If border counties tend to be more urban/rural than the average coroner county, readers can better assess external validity. Consider weighting the border sample (or estimating treatment effect heterogeneity) to explore whether the detection gap differs by, say, population density or state policy environment.

3. **Clarify the mechanism and consider intermediate outcomes.** While toxicology capacity is plausibly central, can the paper provide direct evidence (even if only suggestive) that coroner counties perform fewer autopsies or less toxicology? Data from the 2018 COMEC census include autopsy rate proxies; if accessible, use them to show that coroner counties have lower toxicology/autopsy rates and that these rates correlate with the detection gap. If direct data are unavailable, qualitative descriptions or citations of prior studies can still strengthen the causal story by linking institutional professionalization to forensic practices.

4. **Discuss alternative estimation approaches.** Border-pair fixed effects are informative, but an event-study with county trends or an instrumental-variable strategy (e.g., historical adoption of ME systems) could triangulate the finding. Even if not pursued fully, explaining why border pairs are preferred and why other approaches were infeasible helps readers understand the robustness of the identification.

5. **Refine the national undercount calculation.** Present sensitivity checks that show how the 2,356-death estimate changes under alternative assumptions (e.g., using the more conservative border-pair estimate of −1.7/100k or the pair-by-year estimate of −0.84/100k). This could be framed as a range (or scenario analysis) that acknowledges uncertainty and dependence on the identifying assumptions. Additionally, explicitly state the assumption that coroner-metropolitan prevalence in the 2019 population mirrors that of the border sample.

6. **Expand the discussion of implications.** The argument that every county-level regression is biased by MDI type is strong but somewhat schematic. Could the authors simulate how including a coroner indicator (or adjusting counts by the estimated gap) affects a stylized regression of overdose deaths on, say, Medicaid expansion? Even a back-of-the-envelope adjustment would make the implications for the research community more concrete. Alternatively, suggest how future researchers might incorporate this correction (e.g., include MDI dummies, instrument for local measurement) in applied work.

7. **Document data sources and code access.** Enhance transparency by providing more detail on the construction of the county panel, including how adjacency was defined (contiguity vs. Queen’s vs. rook) and how demographic controls were interpolated over time. If feasible, post replication code/data or point to a repository (beyond the general project URL) to facilitate verification.

8. **Polish the presentation.** Table 2’s time-interacted estimates could benefit from a figure illustrating the gap over time, with confidence intervals. Additionally, clarifying the labels in Table 3 (e.g., specifying which models the robustness checks refer to) would improve readability. The appendix table is helpful; consider incorporating a short paragraph in the main text interpreting the standardized effect size to give readers intuition about magnitude.

In sum, this paper addresses an important gap in the measurement of the opioid crisis, and the border-county design is appealing. By providing more direct evidence for the identifying assumption, clarifying the scope of the national extrapolation, and enriching the discussion of mechanisms and implications, the authors can make a convincing case that medicolegal institutional quality materially biases county-level overdose statistics.
